SVF
Level C· Early Human ResearchRetrospective Study

Use of Ancillary Procedures in Combination with the MACS-Lift for Facial Rejuvenation: A Retrospective Cohort Study.

Sommar P., Law J., Ongena J., Verpaele A., Tonnard P.

Retrospective Study with a reported sample of 380 on Chronic Wound, Skin Aging, Facial Rejuvenation, published in Aesthetic Plast Surg (2026) — summary generated from the PubMed abstract.

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Retrospective Study
Journal
Aesthetic Plast Surg (2026)
Country
United States
Reported sample size
380
PMID
40906287
DOI
10.1007/s00266-025-05143-w

Abstract (original English)

While facelifts remain central to facial rejuvenation, ancillary procedures are essential for addressing aspects of aging not corrected by facelifting alone, such as soft tissue atrophy and skin quality. Despite their routine use, few reviews describe their role alongside facelifts in modern practice. To define the range of ancillary procedures used with the Minimal Access Cranial Suspension (MACS) lift in current practice. A retrospective review was conducted on all MACS-lift procedures performed by the senior authors from January 1, 2018, to December 31, 2024. Data collected included demographics, surgical and ancillary procedures, and complications. The MACS-lift technique has evolved to include deep neck reduction, centrofacial lipofilling, and skin resurfacing. Among 380 patients (356 females, 24 males), 81.8% underwent a primary facelift. Ancillary procedures were performed in 98.9% of cases, with an average of 5.8 procedures per patient, with this average being higher for female than for male patients (6.0 vs 4.5), and higher for patients 55 years or older than for younger patients (6.17 vs 5.13). The most common ancillary procedures were lipofilling (96.3%), brow lift (72.6%) neck lift (67.9%), nanofat microneedling (64.7%), blepharoplasty (57.4%), and lip lift (27.6%). Mean operative time was 3.93 hours. No major complications occurred. Minor complications included neu

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples, often without a control group.

How we grade evidence
HumansRetrospective StudiesFemaleMaleRejuvenationMiddle AgedRhytidoplastyAdultSkin AgingAged
Face & SkinChronic WoundSkin AgingFacial Rejuvenation
View on PubMedDOI

Related research